![Joseph Limber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Limber
Direktör/Styrelseledamot på
XOMA ROYALTY CORPORATION
Förmögenhet: 1 M $ per 2026-05-31
Profil
Joseph M.
Limber is currently Chief Executive Officer at Garda Therapeutics, Inc. and Independent Director at XOMA Royalty Corp.
Formerly, Mr. Limber was President & Chief Executive Officer at Monogram Biosciences, Inc. from 1998 to 2002; President & Chief Executive Officer at Deltagen, Inc. in 2003; President, Chief Executive Officer & Director at Genoptix, Inc. from 2017 to 2018; President & Chief Executive Officer at Gradalis, Inc. from 2013 to 2015; President, Chief Executive Officer & Director at Prometheus Laboratories, Inc. from 2004 to 2013; President, Chief Executive Officer & Director at Secura Bio, Inc.; Chairman at Molecular Insight Pharmaceuticals, Inc. in 2010; Executive Chairman at ImaginAb, Inc. from 2016 to 2017; Director at V.I.
Technologies, Inc.; Independent Non-Executive Director at CombiMatrix Corp.
in 2012; Director at Panacos Pharmaceuticals, Inc. from 2001 to 2009; Executive Vice President at SEQUUS Pharmaceuticals, Inc.; and President & Chief Operating Officer at Praecis Pharmaceuticals, Inc. from 1996 to 1998.
Education includes undergraduate studies at Duquesne University of The Holy Spirit.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-05-21 | 12 820 ( 0,1 % ) | 534 722 $ | 2026-05-31 | |
| 2026-05-21 | 20 000 ( 1,14 % ) | 506 800 $ | 2026-05-31 | |
| 2026-05-21 | 10 000 ( 1,02 % ) | 254 550 $ | 2026-05-31 |
Aktiva positioner av Joseph Limber
| Företag | Position | Start |
|---|---|---|
| XOMA ROYALTY CORPORATION | Direktör/Styrelseledamot | 2012-12-13 |
Tidigare kända positioner av Joseph Limber
| Företag | Position | Slut |
|---|---|---|
Genoptix, Inc.
 Genoptix, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine services | Verkställande Direktör | 2018-12-01 |
ImaginAb, Inc.
 ImaginAb, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing radiopharmaceutical and imaging agent products | Ordförande | 2017-11-01 |
Gradalis, Inc.
 Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Verkställande Direktör | 2015-04-01 |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Verkställande Direktör | 2013-04-01 |
| COMBIMATRIX CORP | Direktör/Styrelseledamot | 2012-10-09 |
Joseph Limbers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
68
Första gradens relationer
15
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 15 |
|---|---|
SEQUUS Pharmaceuticals, Inc.
 SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases | Health Technology |
V.I. Technologies, Inc.
 V.I. Technologies, Inc. BiotechnologyHealth Technology Develops blood products and systems using its proprietary viral inactivation technologies | Health Technology |
Praecis Pharmaceuticals, Inc.
 Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies for the treatment of cancer | Health Technology |
XOMA Royalty Corp.
 XOMA Royalty Corp. Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapeutics | Health Technology |
Monogram Biosciences, Inc.
 Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services for HIV treatment | Commercial Services |
Deltagen, Inc.
 Deltagen, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug discovery tools and services to the biopharmaceutical industry | Commercial Services |
CombiMatrix Corp.
 CombiMatrix Corp. Medical/Nursing ServicesHealth Services Provides molecular diagnostic services | Health Services |
Genoptix, Inc.
Genoptix, Inc. Medical SpecialtiesHealth Technology Provides personalized medicine services | Health Technology |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes innovative molecular imaging pharmaceuticals | Health Services |
Gradalis, Inc.
Gradalis, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
Duquesne University of The Holy Spirit
 Duquesne University of The Holy Spirit Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel pharmaceutical and diagnostic products | Health Technology |
Panacos Pharmaceuticals, Inc.
 Panacos Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small molecule drugs | Health Technology |
ImaginAb, Inc.
ImaginAb, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing radiopharmaceutical and imaging agent products | Health Technology |
Secura Bio, Inc.
 Secura Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products for oncology therapies | Health Technology |
